Rubicon Research
add_icon

Rubicon Research

931.00
+3.50
(0.38%)
Market Cap
15,338.25 Cr
PE Ratio
74.10
Volume
250.00
Day High - Low
948.00 - 916.90
52W High-Low
952.70 - 570.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
15,338.25 Cr
EPS
8.82
PE Ratio
74.10
PB Ratio
13.32
Book Value
69.66
EBITDA
267.90
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
24.84
Debt to Equity
0.91
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
negative
Rubicon Research Limited received Income Tax Assessment Order for AY 2023-24 with demand of ₹17.25 crores related to transfer pricing adjustments and penalty proceedings initiated.
positive
Rubicon Research announces acquisition of 85% stake in Arinna Lifesciences for ₹175.92 crores, entering Indian CNS formulations market. Motilal Oswal raises target to ₹955.
neutral
Rubicon Research Limited receives SEBI compliance certificate from MUFG Intime India for quarter ended March 31, 2026, confirming adherence to dematerialisation regulations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,678.00
#1 4,02,608.41
36.80
#1 54,729.00
9.71
#1 10,980
16.07
42.76
6,375.00
1,69,236.22
68.31
9,712.00
18.67
2,191
-1.02
64.61
4,141.10
1,40,153.64
61.76
11,539.40
6.99
1,911
26.24
48.05
1,325.00
1,10,590.20
20.15
33,741.20
16.73
5,725
-15.28
65.07
2,347.60
1,07,295.47
22.91
22,909.50
13.74
3,306
#1 37.44
57.36
1,307.00
1,05,576.93
23.27
28,409.50
7.12
5,291
-57.18
64.00
946.70
95,260.17
#1 18.96
23,511.00
18.55
4,615
-0.32
63.05
2,299.70
94,932.78
52.47
12,744.20
#1 20.90
2,007
7.65
72.17
1,440.00
83,635.43
23.93
32,345.60
9.43
3,484
7.59
73.85
2,348.00
66,260.75
61.93
13,435.50
6.18
1,047
15.86
68.92
Growth Rate
Revenue Growth
48.58 %
Net Income Growth
47.69 %
Cash Flow Change
657.64 %
ROE
5.08 %
ROCE
39.15 %
EBITDA Margin (Avg.)
4.18 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
317
299
314
358
353
413
479
Expenses
257
234
244
286
273
318
367
EBITDA
61
64
70
73
80
95
112
Operating Profit %
19 %
21 %
22 %
20 %
22 %
23 %
23 %
Depreciation
9
8
9
10
10
12
12
Interest
10
7
8
12
11
11
10
Profit Before Tax
41
49
53
51
60
72
91
Tax
16
15
15
15
16
18
18
Net Profit
26
35
38
36
43
54
73
EPS in ₹
1.66
2.27
2.50
2.35
2.81
3.49
4.46

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
430
538
560
750
1,110
1,451
Fixed Assets
157
188
193
199
307
327
Current Assets
265
340
328
502
763
1,063
Capital Work in Progress
2
6
3
25
10
7
Investments
19
14
0
0
0
0
Other Assets
252
331
364
526
793
1,118
Total Equity & Liabilities
430
538
560
750
1,110
1,451
Current Liabilities
78
111
184
361
573
786
Non Current Liabilities
12
53
71
102
152
124
Total Equity
341
374
305
286
385
541
Reserve & Surplus
335
369
300
281
370
526
Share Capital
5
5
5
5
15
15

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
67
-46
16
-4
54
Investing Activities
-84
-46
-46
-32
-68
-65
Operating Activities
6
62
-63
-75
21
159
Financing Activities
80
52
63
123
44
-40

Share Holding

% Holding
Jul 2024
Sept 2025
Oct 2025
Dec 2025
Mar 2026
Promoter
84.15 %
59.99 %
59.99 %
59.99 %
59.86 %
FIIs
0.00 %
9.37 %
9.37 %
7.99 %
7.54 %
DIIs
0.00 %
10.54 %
10.54 %
9.45 %
10.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.28 %
18.28 %
2.71 %
2.82 %
Others
15.85 %
1.82 %
1.82 %
19.86 %
19.76 %
No of Share Holders
15
1,05,311
1,05,311
31,914
33,738

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 638.50 627.25
03 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Feb 2026 650.05 688.90

Announcements

Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)1 day ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
Announcement under Regulation 30 (LODR)-Acquisition8 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201810 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 31, 2026
Closure of Trading WindowMar 31, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 16, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 16, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 13, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 06, 2026
Newspaper Publication - Financial ResultsFeb 05, 2026
General UpdatesFeb 03, 2026
Announcement Under Regulation 30 - Appointment Of Secretarial AuditorFeb 03, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 03, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorFeb 03, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday February 03 2026Feb 03, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 03, 2026
Results - Financial Results For 31-12-2025Feb 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 03, 2026
Intimation Under Regulation 30 Read With Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Tuesday 03Rd February 2026 Inter-Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 3Jan 27, 2026
Announcement under Regulation 30 (LODR)-AcquisitionJan 14, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Jan 06, 2026
Closure of Trading WindowDec 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 08, 2025
Intimation For Updation Of Corporate Identification Number ("CIN") Of The CompanyNov 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 18, 2025
Newspaper Publication - Financial ResultsNov 14, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 13Th November 2025Nov 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Results-Financial Results For 30-09-2025Nov 13, 2025
Reporting Of Violations Under SEBI (Prohibition Of Insider Trading) Regulations 2015.Nov 13, 2025
Newspaper Publication - Notice Of Postal BallotNov 08, 2025
Notice Of Postal BallotNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday 13Th November 2025.Nov 07, 2025
Announcement under Regulation 30 (LODR)-AcquisitionOct 28, 2025
Announcement under Regulation 30 (LODR)-AcquisitionOct 21, 2025
Closure of Trading WindowOct 17, 2025
Listing of Equity Shares of Rubicon Research LtdOct 16, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bajaj Finserv Small Cap Fund Direct-Growth
3.34%
22500
0.29%
1.20%
ICICI Prudential Exports and Services Fund Direct-Growth
0.84%
0
0.00%
0.07%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.01%
Bajaj Finserv Healthcare Fund Direct-Growth
3.84%
0
0.00%
0.14%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
0.88%
0
0.00%
0.04%
Bajaj Finserv Balanced Advantage Fund Direct-Growth
0.98%
0
0.00%
0.29%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.15%
0
0.00%
0.15%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.01%
Canara Robeco Manufacturing Fund Direct-Growth
2.05%
0
0.00%
0.21%
Edelweiss Recently Listed IPO Fund Direct-Growth
1.77%
0
0.00%
0.11%
Groww Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.01%
HDFC Business Cycle Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Innovation Fund Direct-Growth
1.61%
0
0.11%
0.31%
HDFC Pharma And Healthcare Fund Direct-Growth
1.24%
0
0.00%
0.02%
Angel One Nifty Total Market Index Fund Direct-Growth
0.01%
0
0.00%
0.01%
Bajaj Finserv Flexi Cap Fund Direct-Growth
1.23%
0
0.00%
0.38%
Kotak Manufacture in India Fund Direct-Growth
2.66%
0
0.00%
0.24%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth
0.00%
0
0.00%
-0.26%
Kotak Midcap Fund Direct-Growth
0.52%
0
0.00%
0.09%
Mirae Asset Healthcare Fund Direct-Growth
0.85%
0
0.00%
-0.17%
Kotak Healthcare Fund Direct-Growth
1.75%
0
0.00%
0.09%
Motilal Oswal Nifty Microcap 250 Index Fund Direct-Growth
0.27%
0
0.00%
0.27%
Motilal Oswal Small Cap Fund Direct-Growth
3.78%
0
0.00%
0.52%
PGIM India ELSS Tax Saver Fund Direct-Growth
1.17%
0
0.00%
0.13%
PGIM India Flexi Cap Fund Direct-Growth
0.41%
0
0.00%
0.04%

Technical Indicators

RSI(14)
Neutral
72.09
ATR(14)
Less Volatile
35.12
STOCH(9,6)
Overbought
85.19
STOCH RSI(14)
Overbought
92.85
MACD(12,26)
Bullish
12.57
ADX(14)
Strong Trend
42.40
UO(9)
Bearish
50.85
ROC(12)
Uptrend But Slowing Down
19.58
WillR(14)
Overbought
-13.25